20
Copperhead Investments Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SDM 27 (10% NITROGLYCERIN IN PROPYLENE GLYCOL), with a corresponding US DMF Number 4313.
Remarkably, this DMF maintains an Active status since its submission on November 03, 1981, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 01, 2022, and payment made on July 27, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II